CY1115097T1 - Πεπτιδια - Google Patents
ΠεπτιδιαInfo
- Publication number
- CY1115097T1 CY1115097T1 CY20141100290T CY141100290T CY1115097T1 CY 1115097 T1 CY1115097 T1 CY 1115097T1 CY 20141100290 T CY20141100290 T CY 20141100290T CY 141100290 T CY141100290 T CY 141100290T CY 1115097 T1 CY1115097 T1 CY 1115097T1
- Authority
- CY
- Cyprus
- Prior art keywords
- epitope
- amino acids
- domain
- target ligand
- restricted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
Abstract
Ένα εσωτερικά περιορισμένο κυκλικό ολιγοπεπτίδιο το οποίο περιλαμβάνει έναν δακτύλιο από τουλάχιστον έξι αμινοξέα για ειδική δέσμευση σε έναν προσδέτη στόχο, όπου ο δακτύλιος περιλαμβάνει ένα πλήθος τομέων αμινοξέων, με έκαστο τομέα να περιλαμβάνει τουλάχιστον δύο αμινοξέα τα οποία σχηματίζουν επίτοπο, και δύο ή περισσότερες συνδετικές δραστικές ομάδες τοποθετημένες έτσι ώστε αυτές να σχηματίζουν μία ή περισσότερες ενδο-κυκλικές συνδέσεις' δια των οποίων το κυκλικό ολιγοπεπτίδιο περιορίζεται σε μια απλή διαμόρφωση έτσι ώστε τα αμινοξέα που σχηματίζουν επίτοπο να σχηματίζουν έναν επίτοπο σε έκαστο τομέα, με έκαστο επίτοπο να είναι ικανός να δεσμεύεται ειδικά σε έναν προσδέτη στόχο.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0618512.8A GB0618512D0 (en) | 2006-09-20 | 2006-09-20 | Peptides |
GB0707626A GB0707626D0 (en) | 2007-04-19 | 2007-04-19 | Peptides |
EP07823917.5A EP2081952B1 (en) | 2006-09-20 | 2007-09-20 | Peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115097T1 true CY1115097T1 (el) | 2016-12-14 |
Family
ID=39048085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100290T CY1115097T1 (el) | 2006-09-20 | 2014-04-16 | Πεπτιδια |
Country Status (16)
Country | Link |
---|---|
US (2) | US9096650B2 (el) |
EP (1) | EP2081952B1 (el) |
JP (1) | JP5475451B2 (el) |
KR (1) | KR20090079199A (el) |
AU (1) | AU2007298717B2 (el) |
BR (1) | BRPI0716891A2 (el) |
CA (1) | CA2664064A1 (el) |
CY (1) | CY1115097T1 (el) |
DK (1) | DK2081952T3 (el) |
ES (1) | ES2459020T3 (el) |
IL (1) | IL197675A (el) |
PL (1) | PL2081952T3 (el) |
PT (1) | PT2081952E (el) |
RU (1) | RU2496789C2 (el) |
SI (1) | SI2081952T1 (el) |
WO (1) | WO2008035093A2 (el) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6754997B2 (ja) * | 2013-08-26 | 2020-09-16 | 国立大学法人 東京大学 | 大環状ペプチド、その製造方法、及び大環状ペプチドライブラリを用いるスクリーニング方法 |
CN108474795B (zh) | 2015-04-20 | 2021-10-29 | 豪夫迈·罗氏有限公司 | 经由系统发现、成熟和延伸过程鉴定的针对蛋白质的特异性肽结合剂 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000143698A (ja) * | 1998-11-12 | 2000-05-26 | Japan Science & Technology Corp | グラミシジン類縁体環状ペプチド及びそれを用いた親油性有機化合物の補捉剤 |
GB9915074D0 (en) * | 1999-06-28 | 1999-08-25 | Cortecs Plc | Ligand-binding composition |
WO2006043933A1 (en) * | 2004-10-15 | 2006-04-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Serine protease inhibitors |
-
2007
- 2007-09-20 SI SI200731446T patent/SI2081952T1/sl unknown
- 2007-09-20 DK DK07823917.5T patent/DK2081952T3/da active
- 2007-09-20 EP EP07823917.5A patent/EP2081952B1/en not_active Not-in-force
- 2007-09-20 AU AU2007298717A patent/AU2007298717B2/en not_active Ceased
- 2007-09-20 PL PL07823917T patent/PL2081952T3/pl unknown
- 2007-09-20 PT PT78239175T patent/PT2081952E/pt unknown
- 2007-09-20 JP JP2009528784A patent/JP5475451B2/ja not_active Expired - Fee Related
- 2007-09-20 ES ES07823917.5T patent/ES2459020T3/es active Active
- 2007-09-20 RU RU2009114708/04A patent/RU2496789C2/ru not_active IP Right Cessation
- 2007-09-20 KR KR1020097007727A patent/KR20090079199A/ko active IP Right Grant
- 2007-09-20 BR BRPI0716891-8A patent/BRPI0716891A2/pt not_active IP Right Cessation
- 2007-09-20 CA CA002664064A patent/CA2664064A1/en not_active Abandoned
- 2007-09-20 US US12/442,172 patent/US9096650B2/en not_active Expired - Fee Related
- 2007-09-20 WO PCT/GB2007/003592 patent/WO2008035093A2/en active Application Filing
-
2009
- 2009-03-18 IL IL197675A patent/IL197675A/en not_active IP Right Cessation
-
2014
- 2014-04-16 CY CY20141100290T patent/CY1115097T1/el unknown
-
2015
- 2015-07-10 US US14/796,407 patent/US20150307557A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2081952A2 (en) | 2009-07-29 |
DK2081952T3 (da) | 2014-04-28 |
US20150307557A1 (en) | 2015-10-29 |
RU2496789C2 (ru) | 2013-10-27 |
WO2008035093A3 (en) | 2008-10-02 |
BRPI0716891A2 (pt) | 2013-10-22 |
PL2081952T3 (pl) | 2014-07-31 |
AU2007298717B2 (en) | 2013-05-02 |
ES2459020T3 (es) | 2014-05-07 |
JP2010504313A (ja) | 2010-02-12 |
CA2664064A1 (en) | 2008-03-27 |
WO2008035093A2 (en) | 2008-03-27 |
IL197675A (en) | 2014-06-30 |
US20100022448A1 (en) | 2010-01-28 |
KR20090079199A (ko) | 2009-07-21 |
AU2007298717A1 (en) | 2008-03-27 |
PT2081952E (pt) | 2014-04-30 |
EP2081952B1 (en) | 2014-01-22 |
JP5475451B2 (ja) | 2014-04-16 |
RU2009114708A (ru) | 2010-10-27 |
US9096650B2 (en) | 2015-08-04 |
SI2081952T1 (sl) | 2014-05-30 |
IL197675A0 (en) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120822T1 (el) | Διαειδικα ειδικη επικρατεια δεσμευσης | |
CY1120471T1 (el) | Αντισωματα κατα του cd70 | |
CY1119647T1 (el) | Αντισωματα προσδεσης αλβουμινης και τμηματα προσδεσης αυτων | |
CY1119508T1 (el) | Κυτταροτοξικη ανοσοσφαιρινη | |
CY1124384T1 (el) | Κατασκευες διπλοειδικων αντισωματων που δεσμευονται σε egfrviii και cd3 | |
CY1122494T1 (el) | Πρωτεϊνες συντηξης οι οποιες περιλαμβανουν μια πρωτεϊνη δεσμευσης και ενα πολυπεπτιδιο ιντερλευκινης-15 το οποιο εχει μια μειωμενη συγγενεια για il15ra και θεραπευτικες χρησεις αυτων | |
CY1120144T1 (el) | Αντισωματα αντι-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων | |
CY1125133T1 (el) | Πρωτεϊνες συνδεσης αντιγονου υποδοχεα a il-17 | |
CY1121672T1 (el) | Αντισωματα που προσδενουν τα il-17a και il-17f | |
CY1114603T1 (el) | ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ | |
CY1123733T1 (el) | Γονιδιακα προϊοντα που εκφραζονται διαφορετικα στους ογκους και η χρηση αυτων | |
CY1119928T1 (el) | Διμερης λειτουργικη συμπληρωματικοτητα επαγομενη απο διττο αντιγονο | |
CY1124091T1 (el) | Βελτιωμενο πολυπεπτιδικο μοριο διπλης ειδικοτητας | |
CO2018009533A2 (es) | Conjugados de amanitina | |
CY1114626T1 (el) | Μεθοδοι κυκλοπολυαιθυλενογλυκολιωσης και πρωτεϊνες/πεπτιδια που παραγονται με αυτες τις μεθοδους | |
CY1120426T1 (el) | Πολυπεπτιδιο ace2 | |
CR11282A (es) | Proteinas enlazadas al antigeno de celula de cepa mcdonough de felino humanas | |
CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
CO6231040A2 (es) | Moleculas y metodos para modular la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9) | |
CY1118880T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
CY1115999T1 (el) | Νεα και ισχυρα mhc- κατηγοριας ιι πεπτιδια που προερχονται απο σουρβιβινη και νευροκανη | |
CR11374A (es) | Proteinas humanas de union a antigenos del gm-csf | |
TR201902400T4 (tr) | Multivalan antijen bağlama Fv molekülü. | |
DK1731605T3 (da) | Cancerantigenpeptider der er afledt af WT1 | |
CO6351750A2 (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteina de complementos c5 |